Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews-Reference-Cited by-同舟云学术

Real-World Effectiveness of Everolimus Subsequent to Different First Targeted Therapies for the Treatment of Metastatic Renal Cell Carcinoma: Synthesis of Retrospective Chart Reviews

Published:2016-04 Issue:2 Volume:14 Page:160-167.e3
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Pal Sumanta K.,Signorovitch James E.,Reichmann William M.,Li Nanxin,Koo Valerie,Liu Zhimei,Perez Jose Ricardo,Vogelzang Nicholas J.

Funder

Novartis

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference51 articles.

1. Targeted therapy in metastatic renal carcinoma;Mattei;Cancer Lett,2014

2. The effect of targeted therapy on overall survival in advanced renal cancer: a study of the National Surveillance Epidemiology and End Results registry database;Vaishampayan;Clin Genitourin Cancer,2014

3. Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: results from the Danish Renal Cancer Group (DARENCA) study-2;Soerensen;Eur J Cancer,2014

4. New agents in renal cell carcinoma;Dabney;Target Oncol,2014

5. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials;Coppin;BJU Int,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry;BMC Cancer;2017-12

2. Sequential Treatment with Pazopanib and Everolimus in Metastatic Renal Cell Carcinoma;Frontiers in Pharmacology;2017-07-20

3. Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers;Future Oncology;2017-06